Medical Committee chairman's correspondence

Executive Committee (31-37): Annual General Meeting 1964 (48-49);

Dr. Colin McDougall (531, 534, 541, 543-550, 552-553, 572):

Medical Committee: Dr. R.J.W. Rees, Executive Committee (62), Invitation to join (38, 46); Medical Committee, Children's work (558, 560-561); Invitation to join (1-3); Invitation to become Chairman (4-5); Indian Association of Leprologists VI Biennial Conference (108, 112-121, 128-129, 143-144); Indo-UK Agreement (153-155); International Seminar on Leprosy 1967 (226-228, 230, 233); LEPRA film "The Name of the Cloud is Ignorance" (178-180, 188, 190); Legacy for leprosy work (554-555, 559); Leprosy Research (511-512, 565-566, 568); Finance (514); Leprosy Review (245, 247, 249-250, 254, 509, 530); Leprosy Study Centre (573); Medical advice; Dr. Cochrane's Unit (194-195); East African Common Services Organization (145, 147, 518); General (217); India (569-570); International Society for the Rehabilitation of the Disabled (215); Meetings (18-26, 127, 131-142); Priorities for support (7, 17, 125); Reagents for India (219-220, 225); Sierra Leone Project (241-243); Prize Essay Competition (556, 563); WHO Expert Advisory Panel on Leprosy (63);

Pilot Eradication Unit (5a-6, 10, 29-30):

Kenya (11-12): Alupe, EAMRC Leprosy Unit (147); Itesio, LEPRA Biochemistry Fellowship, Dr. Philip Draper (13-14, 27-28, 106, 108-111);

Malawi: Finance (37, 38-46, 69-72, 176-177, 201, 204); Ministry of Overseas Development (240); Nuffield Foundation (214); Leverhulme Trust (176-177, 187, 192, 223-224); UNICEF (71-73); Meeting with Dr. Hastings Banda (7a-9); Ministry of Health (47-48, 64, 67-68); Monthly report - January 1967 (234); Pilot Leprosy Control Project (71, 74, 78-90, 92-103, 200); Drugs and Reagents (239); BCG (164, 182, 185-186, 205, 209-210, 213, 229-230, 232, 244, 520-521); Glaxo (521, 529); Dapsone (529-530); Lepromin (218, 221a, 246); Microtome (529); Thalidomide (529); Drug trial (DADDS) (251-253); Equipment; Contact cards (161-163, 183); Microscope (146, 149, 151); Press conference (104); Project Sub-Committee (122); Protocol (130, 150); Drug regimens (170-174); Drug resistance (199); Rehabilitation Service (187, 191-193, 202); Report (532); Research Programme (523, 527); Staff (75-76, 123, 235, 516, 551); Dr. Gordon Currie (37, 107, 122, 124, 146, 168-169, 191, 193, 201-203); Mr. Tony Drake (146); Laboratory technicians (77, 535); Dr. William Lennox (157-160, 189, 192, 196, 198, 206-207, 211-212, 221); Dr. D. Molesworth (105, 124, 526, 533); Miss Dawn Smith (516, 522, 533, 537); Surveys (235); Treatment (235;) Visit by Dr. Rees (48, 52-57, 65-66);

OXFAM (29-20, 37, 39, 41-44, 56-58, 60-61, 74, 56);: Dr. C. M. Ross (11-12, 60-61); Dr. G. Weddell (231); World Health Organisation (29-30, 37, 41-44, 50, 68, 71-73, 238)